Selonsertib Uses, Dosage, Side Effects and more
Selonsertib is under investigation in clinical trial NCT03053050 (Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis).
| Attribute | Details |
|---|---|
| Trade Name | Selonsertib |
| Generic | Selonsertib |
| Selonsertib Other Names | Selonsertib |
| Type | |
| Formula | C24H24FN7O |
| Weight | Average: 445.502 Monoisotopic: 445.202636584 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
